Royal Bank of Canada’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.52M | Buy |
438,032
+425,957
| +3,528% | +$1.47M | ﹤0.01% | 3244 |
|
|
2025
Q1 | $31K | Sell |
12,075
-3,253
| -21% | -$8.35K | ﹤0.01% | 5381 |
|
|
2024
Q4 | $63K | Buy |
15,328
+5,184
| +51% | +$21.3K | ﹤0.01% | 5100 |
|
|
2024
Q3 | $72K | Buy |
10,144
+758
| +8% | +$5.38K | ﹤0.01% | 5069 |
|
|
2024
Q2 | $61K | Buy |
9,386
+7,264
| +342% | +$47.2K | ﹤0.01% | 5170 |
|
|
2024
Q1 | $18K | Sell |
2,122
-25,675
| -92% | -$218K | ﹤0.01% | 5526 |
|
|
2023
Q4 | $306K | Buy |
27,797
+12,639
| +83% | +$139K | ﹤0.01% | 4204 |
|
|
2023
Q3 | $127K | Buy |
15,158
+5,738
| +61% | +$48.1K | ﹤0.01% | 4719 |
|
|
2023
Q2 | $118K | Buy |
9,420
+4,602
| +96% | +$57.6K | ﹤0.01% | 4761 |
|
|
2023
Q1 | $79K | Sell |
4,818
-9,632
| -67% | -$158K | ﹤0.01% | 4974 |
|
|
2022
Q4 | $216K | Buy |
14,450
+13,163
| +1,023% | +$197K | ﹤0.01% | 4358 |
|
|
2022
Q3 | $29K | Buy |
1,287
+856
| +199% | +$19.3K | ﹤0.01% | 5508 |
|
|
2022
Q2 | $7K | Sell |
431
-3,868
| -90% | -$62.8K | ﹤0.01% | 6060 |
|
|
2022
Q1 | $129K | Sell |
4,299
-26,429
| -86% | -$793K | ﹤0.01% | 4989 |
|
|
2021
Q4 | $944K | Buy |
30,728
+11,578
| +60% | +$356K | ﹤0.01% | 3404 |
|
|
2021
Q3 | $605K | Buy |
19,150
+14,997
| +361% | +$474K | ﹤0.01% | 3728 |
|
|
2021
Q2 | $152K | Buy |
4,153
+388
| +10% | +$14.2K | ﹤0.01% | 4824 |
|
|
2021
Q1 | $130K | Buy |
3,765
+3,422
| +998% | +$118K | ﹤0.01% | 4794 |
|
|
2020
Q4 | $14K | Buy |
343
+314
| +1,083% | +$12.8K | ﹤0.01% | 5678 |
|
|
2020
Q3 | $1K | Buy |
+29
| New | +$1K | ﹤0.01% | 5973 |
|